Important New Advance in Breast Cancer Treatment: Intraoperative Radiation Therapy
June 6, 2010 by admin
Filed under Weekly Health Update
Welcome to Weekly Health Update“A critical weekly review of important new research findings for health-conscious readers”
IMPORTANT NEW ADVANCE IN BREAST CANCER TREATMENT: INTRAOPERATIVE RADIATION THERAPY The surgical management of breast cancer has undergone several very important revolutions over the past 20 years. When I began medical school, there was essentially only one treatment available to women newly diagnosed with breast cancer. Irrespective of how small or how large the tumor, every woman was advised to undergo complete removal of her breast (mastectomy). Likewise, a radical removal of the lymph nodes in the armpit area, on the same side as the breast cancer, was also considered mandatory back then, even if there were no clinically enlarged lymph nodes detected prior to surgery. Thanks to a landmark prospective clinical research study, conducted by the National Surgical Adjuvant Breast and Bowel Project (NSABP) cancer study group, we know that radical mastectomy offers no improvement in breast cancer survival when compared to simply removing the breast tumor with a margin of normal surrounding breast tissue (partial mastectomy, also known as “lumpectomy”). The NSABP B-04 study, which was initiated in 1971, has now reached an average duration of patient follow-up of nearly 30 years, and the compelling findings of this study have made it possible for hundreds of thousands of women with breast cancer to preserve their breasts. More recently, the application of the sentinel lymph node (SLN) concept has enabled surgeons to locate the one, or a couple, of lymph nodes most likely to contain breast cancer cells. By removing a very small number of SLNs, the complications associated with removal of the armpit (axillary) lymph nodes can be reduced by ten-fold when compared to removal of most of the lymph nodes in the axilla. Since 60 to 65 percent of all breast cancer patients will not have their SLNs involved with breast cancer cells, the vast majority of these women are now able to avoid a complete axillary lymph node dissection, and its associated 30 to 35 percent incidence of complications, including chronic swelling of the arm (lymphedema), numbness or chronic discomfort the arm, and decreased shoulder mobility and strength. (Unfortunately, at the present time, women with “positive” SLNs are still advised to have their remaining armpit lymph nodes surgically removed.) For most women, “breast-conserving” surgery carries an additional price, though. Radiation treatments are administered to the breast after all other treatment has been completed, as this has been shown to cut the risk of recurrence of cancer within the same breast in half. For most patients, conventional “external beam” radiation therapy lasts approximately 5 weeks. Although these treatments are given on an outpatient basis (Monday through Friday, typically), this somewhat prolonged duration of treatment is enough of an inconvenience to some breast cancer patients that they, ultimately, decide to undergo mastectomy instead of lumpectomy combined with radiation. A number of techniques have been devised to speed up the process of radiation therapy for breast cancer patients. These approved methods of accelerated breast irradiation include the use of more frequent treatment sessions, using a standard “external beam” radiation machine, as well as various forms of radiation treatments collectively referred to as brachytherapy. Unlike external beam irradiation, where beams of radiation pass from a machine, and through space, before entering the breast from outside the body, brachytherapy techniques all involve placing a device inside the breast (within the lumpectomy cavity). These catheter-based brachytherapy devices are then loaded with radioactive seeds that emit therapeutic radiation to the inside of the breast. Based upon recent research data, brachytherapy appears to be just as effective as conventional external beam irradiation in reducing the risk of breast cancer local recurrence. However, both brachytherapy and other forms of accelerated breast irradiation still require 1 to 2 weeks of treatment. One potential alternative to standard accelerated breast irradiation methods has been the use of a one-time treatment of the lumpectomy cavity with radiation at the same time that the patient undergoes lumpectomy in the operating room. Intraoperative radiation therapy has been utilized for other types of cancer, primarily within the abdomen, but its usefulness in treating breast cancer has been less clear. Now, a newly published prospective, multi-institutional clinical study, just published in the journal Lancet, offers hope that a single application of radiation, administered while the patient is still under anesthesia at the time of her lumpectomy, might be able to replace the more cumbersome and time-consuming radiation therapy modalities currently in use. This clinical trial was started in 2000, and enrolled 2232 women with newly diagnosed breast cancer. Half of these women underwent conventional external beam radiation therapy, while the other half of these volunteers underwent a single episode of intraoperative radiation treatment at the time of their breast cancer surgery (it should be noted that 14 percent of the women who were randomized to receive intraoperative radiation therapy also subsequently received external beam irradiation as well). After an average follow-up duration of 4 years, there was no significant difference in the incidence of local breast cancer recurrence between these two groups of women. Moreover, the incidence of complications associated with radiation therapy was significantly lower in the group of patients who underwent a single intraoperative treatment with radiation when compared to the conventional external beam radiation therapy group. While the 4-year follow-up of this group of breast cancer patients is too brief to definitively conclude that a single dose of intraoperative radiation provides equivalent long-term protection against local breast cancer recurrence when compared to external beam irradiation and brachytherapy, this study still offers the hope of yet another significant advancement in the treatment of breast cancer. If intraoperative radiation therapy appears to be as effective as conventional breast irradiation after at least 10 years of patient follow-up, then I predict that eligible breast cancer patients will, someday, be routinely treated in this manner. Ultimately, this approach to breast cancer treatment has the potential to significantly increase the efficiency and speed of patient care while simultaneously decreasing the overall cost of such care. It will also improve the quality of the lives of millions of women, over time, and free them to move on with their lives more quickly after receiving the diagnosis of breast cancer.
To learn more about the prevention of breast cancer, and other cancers, look for the publication of my new landmark book, “A Cancer Prevention Guide for the Human Race,” in the summer of this year.
Disclaimer: As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity Dr. Wascher is an oncologic surgeon, a professor of surgery, a cancer researcher, an oncology consultant, and a widely published author For a different perspective on Dr. Wascher, please click on the following YouTube link: http://www.youtube.com/watch?v=7-Tdv7XW0qg I and the staff of Weekly Health Update would like to take this opportunity to thank the more than 100,000 new and returning readers who visit our premier global health information website every month. As always, we enjoy receiving your stimulating feedback and questions, and I will continue to try and personally answer as many of your inquiries as I possibly can. |
|
|
CT Scans & Cancer Risk
December 20, 2009 by admin
Filed under CT Scans, Cancer, Cancer Prevention
Welcome to Weekly Health Update“A critical weekly review of important new research findings for health-conscious readers”
HAPPY HOLIDAYS FROM WEEKLY HEALTH UPDATE!
CT SCANS & CANCER RISK
CT (computed tomography) scanners have revolutionized the practice of medicine since they were first introduced into routine clinical practice in 1974. CT scanners utilize a rotating x-ray device to create hundreds of individual images that can then be reconstructed into a complex three dimensional view of the body by computers. Current generation CT scanners are able to image the entire human body within seconds, and these high definition images provide physicians with an incredibly detailed view of the organs and tissues deep within us.
CT scanners have become an indispensible diagnostic tool within virtually every medical and surgical specialty, and an estimated 75 million CT scans are now performed annually in the United States, alone. As the popularity of these complex and powerful diagnostic imaging machines has continued to grow, so has their use for clinically dubious reasons. For example, routine scans of the heart, and its coronary arteries, have, increasingly, been used for “screening purposes” in patients without any clinical evidence of heart disease. Likewise, there has been an explosion in the number of private radiology imaging centers offering fee-based “body scans” for clinically healthy people who are interested in having their internal organs examined for any early signs of diseases that can be detected by CT scans. Another area of concern regarding the use of CT scanners is that physicians have become so dependent on these machines, and the exquisite images of the human body that they provide, that many (if not most) doctors have a very low threshold to order CT scans as a routine part of their diagnostic work-up of patients. (For example, in my own specialty of Surgery, the diagnosis of appendicitis is now routinely made with a CT scanner, rather than by the traditional method of the surgeon’s clinical evaluation of the patient.)
While CT scanners have become essential diagnostic tools, they also expose patients to much higher doses of radiation than most conventional x-ray examinations. It has long been known that exposure to radiation increases the risk of developing cancer, and that the risk of developing cancer is proportional to the dose of radiation received by patients. (Based upon recent estimates, it has been estimated that at least 2 percent of all cancer cases may be caused by prior exposure to medical x-rays.) Moreover, there is no known “safe” dose of radiation in terms of radiation-induced cancer risk. As if this was not already bad enough, there has been a growing concern regarding the actual dose of radiation that is being delivered to patients from CT scanners across the country, as there is a great deal of variability in the radiation dose settings being used among different CT scan imaging facilities. (This alarming point was recently brought to the public’s attention when it was revealed that Cedars Sinai Medical Center, a prestigious private hospital in the Beverly Hills area, was being investigated after multiple patients who had undergone CT scans of their brain there began to notice that their hair was falling out. Authorities subsequently determined that these patients had received grossly excessive radiation doses during their scans.)
Two very important public health studies have just been published in the Archives of Internal Medicine, and the findings of these two related studies have significantly raised the level of concern regarding the current use of CT scanners among public health experts.
The first of these two studies quantified the amount of radiation dose delivered to 1,119 patients for 11 common types of CT scan examinations that were performed at 4 different hospitals in the San Francisco area. In addition to calculating the radiation doses received by these patients, the authors also estimated the probable lifetime cancer risk associated with these CT scans. As the Cedars Sinai case has already shown, there appears to be considerable variability in the amount of radiation used at different institutions to conduct the same exact type of CT scan. However, the sheer magnitude of this variability in radiation doses, as measured by these researchers, is both mind-boggling and disturbing. Not only was there an enormous difference in radiation doses associated with performing the same exact type of CT scan between the 4 different institutions that were studied, but significant radiation exposure differences were also present within each individual institution when performing the same type of CT scan examination on different patients. When the researchers had finished their calculations, they noted an almost unbelievable 13-fold difference, on average, in radiation exposure for the same type of CT scan between the highest and lowest observed radiation doses for each individual type of CT examination.
Based largely upon cancer incidence data collected after the Hiroshima and Nagasaki atomic bombings, this clinical study’s researchers calculated that an estimated 1 in 270 women who underwent a CT scans of their coronary arteries at age 40 will eventually develop cancer as a direct result of these CT scans (versus 1 in 600 men), while 1 in 8,100 women who underwent CT scans of the brain at age 40 will develop cancer from these scans (versus 1 in 11,080 men). For men and women who underwent CT scans at age 20 (instead of age 40), the projected lifetime risk of CT scan-associated cancer was nearly double the projected risk of the 40 year-old patients.
The findings of this study indicate that the variability in radiation exposure between hospitals for the same type of CT scan examination is much greater than was previously believed. Perhaps even more surprising was the finding that identical CT scan examinations performed within a single hospital also subjected patients to significantly different amounts of radiation exposure. Finally, the calculated range of radiation exposure for CT scans revealed that, in general, patients are receiving far higher doses of radiation from routine CT scans than has generally been appreciated. (For example, a single CT coronary artery angiogram delivers the same amount of radiation as 310 chest x-rays!)
The second research study used public health data to estimate the average number of radiation-induced cancers caused by CT scans in the United States. Based upon current CT scan use, these researchers predicted that approximately 29,000 future cases of cancer could be expected to arise from CT scans performed in 2007 in the United States, resulting in approximately 15,000 deaths due to cancers caused directly by CT scans!
These two studies are eye-openers that should cause all of us, physicians and patients alike, to reconsider the benefits versus the risks of each and every CT scan that is considered before such scans are performed. Although most CT scans are performed because they offer vitally important clinical information on patients that could only otherwise be obtained by surgical exploration, too many CT scans are still being ordered and performed for far less compelling reasons (one of them being, unquestionably, the tendency of many physicians to order multiple unnecessary tests on patients as part of their practice of “defensive medicine,” in the absence of tort reform throughout most areas of the United States…). Moreover, the striking variation in CT-associated radiation doses, and the unexpectedly high level of these radiation doses in general, points to the need to improve standardization and compliance at every one of the thousands of institutions in the United States that operates a CT scanner. As a dedicated cancer specialist, I am already well aware of the potential for radiation-induced cancers, and I have, for many years, tried to be very selective in ordering CT scans on my patients. In cases where I can gather the necessary clinical information without resorting to radiographic imaging, then I try to avoid obtaining any form of x-ray examination (including CT scans). In other cases, where I must obtain some sort of imaging examination, then I will often initially use ultrasound or MRI studies in place of CT scans, when appropriate. Even so, the dramatic findings of these two studies suggest to me that all physicians need to further decrease their routine use of CT scans whenever possible.
Disclaimer: As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity Dr. Wascher is an oncologic surgeon, a professor of surgery, a cancer researcher, an oncology consultant, and a widely published author
|
|
|
